If today’s hearing was any indication, Dr. Eric Goosby is headed for an easy confirmation to be U.S. Global AIDS Coordinator. Dr. Goobsy’s time in the hot seat, before the Senate Foreign Relations Committee, lasted all of 30 minutes this afternoon, and he wasn’t thrown any hardballs. In his opening remarks, Dr. Goosby talked about […]
In a significant development, the National Institute of Allergy and Infectious Diseases announced that it a trial in Haiti–investigating the impact of earlier ART therapy in HIV-positive patients—would be ended early because the results were overwhelming; the findings showed that HIV-infected adults are more likely to survive if they start antiretroviral drugs before their immune […]
For anyone interested in the fight against global AIDS, today is potentially pivotal. This afternoon, the Senate Foreign Relations Committee will hold a confirmation hearing on Dr. Eric Goosby’s nomination to be U.S. Global AIDS Coordinator. A full Senate vote confirming Goosby cannot come too soon; with Congress set to make funding decisions in the […]
HIV
Since the president’s Feb. 5 State of the Union address pledge to end transmissions of HIV in the United States in the next 10 years, and […]
Tuberculosis
Releasing the most recent domestic and global data on tuberculosis incidence in this week’s Morbidity and Mortality Weekly Report, the U.S. Centers for Disease Control and […]
Research & Development
A trial to test the safety of, and immune response prompted by, the latest candidate for a vaccine to protect against Zika virus infection has begun […]
Policy
The following is a guest post by Emily Weaver, PhD, of MEASURE Evaluation Health projects and donors in low-resource countries increasingly aim to leverage existing data […]